{"id":411917,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2019-07-08] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-25","captureTimestamp":"2026-01-25T02:51:25.472000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2019-07-08.html","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions Date: July 8, 2019 Our file number: 19-113709-160 The purpose of this Notice of Amendment is to notify about the additions of abemaciclib, cemiplimab, patisiran, and risankizumab to the Prescription Drug List (PDL) for…","rawSnapshotUrl":"/api/snapshots/raw/411917","browseUrl":"https://replay.healtharchive.ca/job-6/20260125025125/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2019-07-08.html#ha_snapshot=411917","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}